圣湘生物
(688289)
| 流通市值：117.73亿 | | | 总市值：117.73亿 |
| 流通股本：5.79亿 | | | 总股本：5.79亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 4,399,107,412.9 | 4,590,157,048.22 | 4,418,063,884.09 | 4,315,046,761.38 |
| 应收票据及应收账款 | 732,237,297.8 | 529,513,385.2 | 611,982,268.98 | 675,070,521.87 |
| 其中：应收票据 | 965,592.09 | 157,100.44 | 3,425,842 | 8,156,721.2 |
| 应收账款 | 731,271,705.71 | 529,356,284.76 | 608,556,426.98 | 666,913,800.67 |
| 应收款项融资 | 20,299,391.62 | 31,180,307.12 | - | - |
| 预付款项 | 87,975,574.37 | 37,211,317.36 | 95,100,249.6 | 56,588,482.38 |
| 其他应收款合计 | 38,867,428.54 | 27,579,557.11 | 25,810,330.05 | 40,444,840.22 |
| 存货 | 363,755,087.28 | 392,754,329.49 | 419,030,490.79 | 391,965,646.8 |
| 其他流动资产 | 30,358,638.32 | 41,493,191.9 | 21,971,759.05 | 21,936,333.95 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 5,776,190,273.85 | 5,789,559,824.3 | 5,742,694,872.97 | 5,903,884,407.31 |
| 非流动资产: | | | | |
| 债权投资 | 3,228,683.05 | 3,209,385.55 | 3,188,876.71 | 3,166,191.78 |
| 长期股权投资 | 361,103,835.58 | 375,107,826.34 | 460,488,241.04 | 453,209,636.01 |
| 其他权益工具投资 | 258,771,156.78 | 245,778,456.05 | 248,178,350.12 | 229,176,030.91 |
| 其他非流动金融资产 | 471,561,178.3 | 471,561,178.3 | 470,959,983.51 | 470,959,983.51 |
| 固定资产 | 1,217,392,222.99 | 1,091,496,466.67 | 1,035,192,508.35 | 1,008,594,060.86 |
| 在建工程 | 20,940,663.83 | 3,577,326.53 | 9,491,484.34 | 3,464,019.09 |
| 使用权资产 | 17,228,486.59 | 17,587,841.29 | 25,752,601.17 | 22,027,205.96 |
| 无形资产 | 516,336,972.38 | 334,665,271.01 | 343,376,027.01 | 278,546,922.81 |
| 开发支出 | 96,936,915.1 | 94,699,216.79 | 85,157,146.77 | 66,395,305.57 |
| 商誉 | 770,809,489.08 | 7,662,244.77 | 7,662,244.77 | 7,662,244.77 |
| 长期待摊费用 | 51,953,107.59 | 52,570,177.48 | 44,664,559.17 | 49,576,949.82 |
| 递延所得税资产 | 75,831,817.09 | 69,276,100.82 | 65,569,362.69 | 67,468,907.8 |
| 其他非流动资产 | 46,020,090.15 | 47,044,827.8 | 28,818,146.45 | 67,948,558.07 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,908,114,618.51 | 2,814,236,319.4 | 2,828,499,532.1 | 2,728,196,016.96 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 9,684,304,892.36 | 8,603,796,143.7 | 8,571,194,405.07 | 8,632,080,424.27 |
| 流动负债: | | | | |
| 短期借款 | 18,000,000 | 9,000,000 | 9,000,000 | 9,000,000 |
| 交易性金融负债 | 500,000,000 | - | - | - |
| 应付票据及应付账款 | 434,039,346.48 | 395,442,741.25 | 421,353,079.35 | 358,359,810.22 |
| 其中：应付票据 | 33,343,230 | 20,807,020.25 | 19,994,790.25 | 9,605,000 |
| 应付账款 | 400,696,116.48 | 374,635,721 | 401,358,289.1 | 348,754,810.22 |
| 合同负债 | 41,180,297.9 | 64,552,011.59 | 27,249,829.75 | 26,454,844.66 |
| 应付职工薪酬 | 103,208,181.12 | 138,739,296.73 | 128,193,927.25 | 133,278,876.08 |
| 应交税费 | 21,825,268.74 | 9,599,682.87 | 12,411,391.73 | 26,353,994.43 |
| 其他应付款合计 | 174,293,787.48 | 131,018,370.47 | 106,351,222.58 | 106,971,915.53 |
| 一年内到期的非流动负债 | 5,057,749.63 | 5,282,192.18 | 9,211,306.77 | 10,142,431.49 |
| 其他流动负债 | 3,639,530.62 | 1,168,836.5 | 508,919.6 | 477,023.75 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,301,244,161.97 | 754,803,131.59 | 714,279,677.03 | 671,038,896.16 |
| 非流动负债: | | | | |
| 长期借款 | 810,162,419.18 | 396,646,274.01 | 400,761,293.84 | 395,561,290.25 |
| 租赁负债 | 11,440,278.5 | 11,924,758.35 | 16,547,760.99 | 13,077,488.44 |
| 递延收益 | 38,193,548.63 | 39,883,290.18 | 31,221,423.56 | 31,648,180.98 |
| 递延所得税负债 | 90,381,037.53 | 54,753,138.84 | 55,316,991.01 | 56,525,156.1 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 950,177,283.84 | 503,207,461.38 | 503,847,469.4 | 496,812,115.77 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,251,421,445.81 | 1,258,010,592.97 | 1,218,127,146.43 | 1,167,851,011.93 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 579,388,006 | 582,388,006 | 583,388,006 | 588,459,803 |
| 资本公积 | 1,601,651,376.38 | 1,701,752,235.02 | 1,748,925,475.49 | 1,900,574,596.5 |
| 减:库存股 | 164,889,977.31 | 274,293,035.06 | 305,945,422.22 | 472,810,381.88 |
| 其他综合收益 | 39,170,856.5 | 39,009,078.22 | 33,819,358.46 | 39,120,491.97 |
| 盈余公积 | 294,229,901.5 | 294,229,901.5 | 294,229,901.5 | 294,229,901.5 |
| 未分配利润 | 4,991,875,164.23 | 4,900,139,680.59 | 4,883,690,491.54 | 4,988,399,843.24 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 7,341,425,327.3 | 7,243,225,866.27 | 7,238,107,810.77 | 7,337,974,254.33 |
| 少数股东权益 | 91,458,119.25 | 102,559,684.46 | 114,959,447.87 | 126,255,158.01 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 7,432,883,446.55 | 7,345,785,550.73 | 7,353,067,258.64 | 7,464,229,412.34 |
| 负债和股东权益合计 | 9,684,304,892.36 | 8,603,796,143.7 | 8,571,194,405.07 | 8,632,080,424.27 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-24 | 2024-08-19 |
| 审计意见(境内) | | 标准无保留意见 | | |